Name
Designations
Role
GMC number
My current role
I am a consultant and academic lead in the department of immunology. I have a research group at the Cambridge Institute for Therapeutic Immunology and Infectious Diseases, University of Cambridge.
Previous history
I moved to Cambridge from Canberra where I was professor of medicine at the Australian National University.
Membership and accreditations
- FRACP
- FRCPA
- FFSc (RCPA)
Publications
-
Howson LJ, et al,. Impaired immunity and absence of mucosal-associated invariant T cells in a person with a homozygous point mutation in MR1. Science Immunol 2020, Jul 24;5(49):eabc9492
-
Wirasinha RC, et al. Nfkb2 Mutations Reveal a p100-Processing Threshold that Defines Autoimmune Susceptibility. J Exp Med 2021. 218 (2): e20200476.
-
He Y, et al,. P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance. J Exp Med 2021, 219 (1), e20211004
-
Arsov T, et al,. Expanding the clinical spectrum of pathogenic variation in nr2f2: asplenia. Eur J Med Genet, 2021, 104347
-
Brown GJ, et al,. Monogenic autoimmunity caused by TLR7 gain-of-function. Nature. 2022, 605(7909):349-356.